Registered entities
IMMUNOMOLECULAR THERAPEUTICS, INC.
Reg. No. 47-2787642United States
Investor mix
6 investors on record; lead investors include T1D Fund, Morningside.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |
Developer of immunomodulatory therapeutics for diabetes treatments
6 investors on record; lead investors include T1D Fund, Morningside.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |